NDC 0074-2340

Norvir

Ritonavir

Norvir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Ritonavir.

Product ID0074-2340_ff281f75-bfea-433a-8d28-d33cdb898f00
NDC0074-2340
Product TypeHuman Prescription Drug
Proprietary NameNorvir
Generic NameRitonavir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-08-16
Marketing CategoryNDA /
Application NumberNDA022417
Labeler NameAbbVie Inc.
Substance NameRITONAVIR
Active Ingredient Strength100 mg/1
Pharm ClassesBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2024-12-31

Packaging

NDC 0074-2340-30

30 TABLET, FILM COATED in 1 BOTTLE (0074-2340-30)
Marketing Start Date2022-08-16
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Norvir" or generic name "Ritonavir"

NDCBrand NameGeneric Name
0074-1940NorvirRitonavir
0074-2340NorvirRitonavir
0074-3333NorvirRitonavir
0074-3399NorvirRitonavir
50090-1162NorvirRitonavir
53808-1119NorvirRitonavir
67296-1234NorvirNorvir
0054-0407RitonavirRitonavir
31722-597RitonavirRitonavir
60687-364RitonavirRitonavir
60687-420RitonavirRitonavir
65162-061RitonavirRitonavir
65862-687RitonavirRitonavir

Trademark Results [Norvir]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NORVIR
NORVIR
74655713 2001944 Live/Registered
ABBVIE INC.
1995-04-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.